+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ASPIRA ASPIRA

Aspira Pathlab & Diagnostics Share Price

₹90.05 -1.8 (-1.96%)
33.73% Fall from 52W High

21 Aug, 2026 4:01 PM (IST)

Aspira Pathlab & Diagnostics live price: ₹90.05. It opened at ₹90 vs previous close ₹92; intraday high/low: ₹90/₹90. The 50 & 200 DMA stand at ₹103.70/₹86.20.

Aspira Pathlab & Diagnostics Performance

  • Today's Low
  • ₹90
  • Today's High
  • ₹90
  • 52 Week Low
  • ₹49
  • 52 Week High
  • ₹136
  • Open Price₹90
  • Previous Close₹92
  • Volume300
  • 50 DMA₹103.70
  • 100 DMA₹97.40
  • 200 DMA₹86.20

Aspira Pathlab & Diagnostics Chart

Investment Returns

  • Over 1 Month -10.44%
  • Over 3 Month -20.56%
  • Over 6 Month + 45.71%
  • Over 1 Year + 53.67%

Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!

Invest Now

Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -204.8
  • PEG Ratio
  • 1.7
  • Market Cap Cr
  • 93
  • P/B Ratio
  • 7.6
  • Average True Range
  • 2.7
  • EPS
  • -0.4
  • Dividend Yield
  • 0
  • MACD Signal
  • -4.3
  • RSI
  • 28.52
  • MFI
  • 2.6

Latest Stock News Updates

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication for the Financial Result as on 30 June 2026

Aspira Pathlab & Diagnostics Ltd - 540788 - Announcement under Regulation 30 (LODR)-Change in Management

1. Board approved the appointment of Mr. Vaibhav Odhekar as Additional Executive Director with immediate Effect. 2. Board Approved the regularization of Mr. Vaibhav Odhekar as Executive Director subject to approval of Shareholder in ensuring Annual general Meeting 3. Board Approved the Re- Designation Of Mr. Nikunj Velji Mange from Executive Director to Managing Director subject to approval of Shareholder in ensuring Annual General Meeting 4. Board Approved the Appointment of M/s. Harsh Kholiya & Co, Practicing Chartered Accountant as an Internal Auditor for Quarter 2,3, and 4 of Financial Year 2026-27

Aspira Pathlab & Diagnostics Ltd - 540788 - Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026

Unaudited Standalone Financial Results for quarter ended 30 June 2026

Aspira Pathlab & Diagnostics Financials

Aspira Pathlab & Diagnostics Technicals

EMA & SMA

Current Price
₹90.05
-1.8 (-1.96%)
pointer
  • Bearish Moving Average 13
  • Bullish Moving Average 3
  • 20 Day
  • ₹101.20
  • 50 Day
  • ₹103.70
  • 100 Day
  • ₹97.40
  • 200 Day
  • ₹86.20

Resistance and Support

90.02 Pivot Speed
  • R3 90.00
  • R2 90.00
  • R1 90.00
  • S1 90.00
  • S2 90.00
  • S3 90.00

Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-12 Quarterly Results & Raising of funds
2026-05-23 Audited Results
2026-02-10 Quarterly Results
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results

Aspira Pathlab & Diagnostics Shareholding Pattern

53.41%
46.58%
0%

About Aspira Pathlab & Diagnostics

Aspira Pathlab & Diagnostics is engaged in the business of running, owning, managing and administering Diagnostics Centres. The principal activities of the Company consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. View More
  • NSE Symbol
  • ASPIRA
  • BSE Symbol
  • 540788
  • Executive Director,Managing Director,Chief Executive Officer
  • Pankaj Jashwant Shah
  • ISIN
  • INE500C01017

Similar Stocks to Aspira Pathlab & Diagnostics

Aspira Pathlab & Diagnostics FAQs

Aspira Pathlab & Diagnostics share price is ₹90 As on 23 August, 2026 | 21:08

The Market Cap of Aspira Pathlab & Diagnostics is ₹92.7 Cr As on 23 August, 2026 | 21:08

The P/E ratio of Aspira Pathlab & Diagnostics is -204.8 As on 23 August, 2026 | 21:08

The PB ratio of Aspira Pathlab & Diagnostics is 7.6 As on 23 August, 2026 | 21:08

The 52 week High & Low of Aspira Pathlab & Diagnostics is ₹135.9/₹49 respectively As on 23 August, 2026 | 21:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23